【金十数据整理：每日港股市场要闻速递（12月31日 周二）】个股新闻1. 中国中车(01766.HK)：近期签订若干项合同，合计金额约693.5亿元，约占公司中国会计准则下2023年营业收入的29.6%。2. 石药集团(01093.HK) ：亮丙瑞林缓释注射液(SYH 9016)获临床试验批准。3. 开拓药业(09939.HK)：KX- 826 酊1.0%治疗中国成年男性雄激素脱发关键性临床试验 III 期阶段完成首例受试者入组。4. 首都创投(02324.HK)：发布截至2024年9月30日止年度业绩，净亏损约1990万港元，同比收窄87%。5. 科济药业(02171.HK)：舒瑞基奥仑赛注射液用于治疗晚期胃╱食管胃结合部腺癌的中国关键II期临床试验取得初步阳性结果。6. 华检医疗(01931.HK)：拟投资人工智能液冷解决方案公司，并申请美国场外交易市场跨境交易。7. 广汽集团(02238.HK)：向控股股东售广巨湾技研股权，涉资约13亿元。8. 融创中国(01918.HK)：融创旗下的“PR融创01”债券重组获持有人会议表决通过。9. 据港交所文件，麦德龙供应链有限公司向港交所提交上市申请书。10. 奇富科技(03660.HK)：董事会授权未来12个月回购至多4.5亿美元股票。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.